Evidence map›Paper›PMID 29941454›Full record

ArticleThe Journal of biological chemistry2018

Peptide-based sequestration of the adaptor protein Nck1 in pancreatic β cells enhances insulin biogenesis and protects against diabetogenic stresses.

George Kefalas, Nathalie Jouvet, Cindy Baldwin, Jennifer L Estall, Louise Larose

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Nck adaptors at a glance.Journal of cell science · 2021
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

George KefalasFrom the Research Institute of the McGill University Health Centre, Montreal, Quebec H4A 3J1, Canada.
Nathalie Jouvetthe Institut de Recherches Cliniques de Montreal, Montreal, Quebec H2W 1R7, Canada.
Cindy BaldwinFrom the Research Institute of the McGill University Health Centre, Montreal, Quebec H4A 3J1, Canada.
Jennifer L Estallthe Division of Experimental Medicine, Department of Medicine, McGill University, Montreal, Quebec H4A 3J1, Canada, and jennifer.estall@ircm.qc.ca.
Louise LaroseFrom the Research Institute of the McGill University Health Centre, Montreal, Quebec H4A 3J1, Canada, louise.larose@mcgill.ca.
McGill University · CAMcGill University Health Centre · CAMontreal Clinical Research Institute · CA

Funding

CIHR PJT-148771CIHR PJT-374589
6 · The paper itself

Abstract

One feature of diabetes is the failure of pancreatic β cells to produce insulin, but the molecular mechanisms leading to this failure remain unclear. Increasing evidence supports a role for protein kinase R-like endoplasmic reticulum kinase (PERK) in the development and function of healthy pancreatic β cells. Previously, our group identified the adaptor protein Nck1 as a negative regulator of PERK. Indeed, we demonstrated that Nck1, by directly binding PERK autophosphorylated on Tyr

Indexed as

Adaptor Proteins, Signal TransducingAnimalsApoptosisCells, CulturedDiabetes MellituseIF-2 KinaseGlucose IntoleranceInsulinInsulinomaInsulin-Secreting CellsMiceOncogene ProteinsPeptide FragmentsPhosphorylationProtective AgentsSignal TransductionAdaptor Proteins, Signal TransducingeIF-2 KinaseInsulinNck proteinOncogene ProteinsPeptide FragmentsProtective Agentsadaptor proteinadaptor protein Nckbeta cell (B-cell)cell-penetrating peptidecell therapydiabetesinsulin secretioninsulin synthesislipotoxicityPERK

Identifiers

PMID29941454
PMCPMC6093234
OpenAlexW2810223831

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.